[
  {
    "sentence": "Proportion of published trials\nFor our whole cohort, 576 (83%) of the 691 trials included were published as a method article or a result article in a medical journal and/or the trial results were made available in study registries; results were available for 555 (80%) of the trials (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For example, only 8% of the trials generated 29% of the publications, resulting in an average publication frequency of 7.0 (median 6) publications per trial.Sub-cohorts\nFor the sub-cohorts, the proportion of trials published varied between 77 and 87% (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "This was visualized as Aalen-Johansen estimators in a stacked probability plot (Fig. 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCumulative incidence functions (Aalen-Johansen estimates)Compared to Public Germany trials, results were published earlier for trials of the other sub-cohorts (Table 3, Fig. 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Frequently stated reasons for the exclusion of publications were that cohorts failed to meet the eligibility criteria and did not report the data of interest.Sub-cohorts\nFor the public sub-cohorts and for Commercial Germany, citation by systematic reviews ranged between 52 and 63% and was higher than in Commercial International with 38% (Fig. 5 and Table 4).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "This difference might be explained by the lower proportion of trials published as journal articles in ISTs (compare Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Both, the type of intervention and the number of primary outcomes are not associated with the inclusion probability, whereas larger trials are significantly more often included in reviews than smaller trials (Additional file 9).Trials included in clinical guidelines\nCohort\nWe found 574 citations of 178 trials (26%) in guidelines (Fig. 6).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Proportion of trials (n = 691) cited by clinical guidelines per sub-cohort and type of publication\n\n\nTrials cited by guideline\nIITPublic Germany govNo. of trials (%)\nIITPublic GermanyotherNo. of trials (%)\nIITPublic Germany(total)No. of trials (%)\nIITPublic InternationalNo. of trials (%)\nISTCommercial GermanyNo. of trials (%)\nISTCommercial InternationalNo. of trials (%)\nTotalNo. of trials(%)\n\n\n\nTotal trials\n60\n60\n120 (100)\n200 (100)\n171 (100)\n200 (100)\n691 (100)\n\n\nTrials in guidelines\n27 (45)\n8 (13)\n35 (29)\n61 (31)\n50 (29)\n32 (16)\n178 (26)\n\n\n95% CI\n32–58\n6–25\n21–38\n24–37\n23–37\n11–22\n23–29\n\nDirect\n\n Trials with method articles in guideline\n7 (12)\n0\n7 (6)\n2 (1)\n0\n1 (< 1)\n10 (1)\n\n\n Trials with result articles in guideline\n19 (32)\n4 (7)\n23 (19)\n36 (18)\n27 (16)\n18 (9)\n104 (15)\n\n\n Trials with register ID in guidelines\n3 (5)\n0\n3 (3)\n2 (1)\n2 (1)\n0\n7 (1)\n\n\n Trials with any direct citation\n25 (42)\n4 (7)\n29 (24)\n38 (19)\n29 (17)\n18 (9)\n114 (16)\n\nIndirect\n\n Trials in guidelines via review\n16 (27)\n8 (13)\n24 (20)\n43 (22)\n35 (20)\n20 (10)\n122 (18)\n\nDirect AND indirect\n\n Trials in guidelines via review AND result article\n12 (20)\n8 (13)\n20 (17)\n42 (21)\n35 (20)\n20 (10)\n117 (17)\n\n\n\nOpen in a new tab\nDirect: guidelines cite the original published article(s); Indirect: guidelines cite systematic review(s) that include the original published article(s)Sub-cohorts\nIn Fig. 7 / Table 5 it is shown that for the sub-cohorts the inclusion of trials in guidelines ranged between 17 and 31%.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Larger trials are about twice as often included in guidelines than smaller trials (Additional file 10).Overall impact\nLifecycle of trials\nFigure 8 shows the fate of the trials included in our cohort from registration to publication and to their impact on clinical practice.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Nevertheless, in our cohort, a relevant percentage did not find an inclusion in clinical practice: only 309 (45%) of the trials were included in systematic reviews and 178 (26%) in guidelines.Cohort\nOf all trials, 274 (40%) generated no impact: 115 (17%) of the trials were not published and of the published trials, 160 (23%) were not cited by either a systematic review or a guideline (Fig. 9).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "The distribution of the three “impact-proportions” concerning inclusion in reviews and/or guidelines showed only minor differences between the sub-cohorts (Fig. 10).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "The high proportion of guidelines in psychiatry and psychotherapy, cardiovascular disease and neurology is related to a high proportion of publications and systematic reviews for these fields (Fig. 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Our results, however, indicate that this only concerns a few trials because since 1) compared to literature, the publication rate of our cohort was relatively high, and 2) the stacked probability plot (Fig. 3) also indicates that only few first publications are to be expected.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Proportion of published trials\nFor our whole cohort, 576 (83%) of the 691 trials included were published as a method article or a result article in a medical journal and/or the trial results were made available in study registries; results were available for 555 (80%) of the trials (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For example, only 8% of the trials generated 29% of the publications, resulting in an average publication frequency of 7.0 (median 6) publications per trial.Sub-cohorts\nFor the sub-cohorts, the proportion of trials published varied between 77 and 87% (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "This was visualized as Aalen-Johansen estimators in a stacked probability plot (Fig. 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCumulative incidence functions (Aalen-Johansen estimates)Compared to Public Germany trials, results were published earlier for trials of the other sub-cohorts (Table 3, Fig. 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Frequently stated reasons for the exclusion of publications were that cohorts failed to meet the eligibility criteria and did not report the data of interest.Sub-cohorts\nFor the public sub-cohorts and for Commercial Germany, citation by systematic reviews ranged between 52 and 63% and was higher than in Commercial International with 38% (Fig. 5 and Table 4).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "This difference might be explained by the lower proportion of trials published as journal articles in ISTs (compare Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Both, the type of intervention and the number of primary outcomes are not associated with the inclusion probability, whereas larger trials are significantly more often included in reviews than smaller trials (Additional file 9).Trials included in clinical guidelines\nCohort\nWe found 574 citations of 178 trials (26%) in guidelines (Fig. 6).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Proportion of trials (n = 691) cited by clinical guidelines per sub-cohort and type of publication\n\n\nTrials cited by guideline\nIITPublic Germany govNo. of trials (%)\nIITPublic GermanyotherNo. of trials (%)\nIITPublic Germany(total)No. of trials (%)\nIITPublic InternationalNo. of trials (%)\nISTCommercial GermanyNo. of trials (%)\nISTCommercial InternationalNo. of trials (%)\nTotalNo. of trials(%)\n\n\n\nTotal trials\n60\n60\n120 (100)\n200 (100)\n171 (100)\n200 (100)\n691 (100)\n\n\nTrials in guidelines\n27 (45)\n8 (13)\n35 (29)\n61 (31)\n50 (29)\n32 (16)\n178 (26)\n\n\n95% CI\n32–58\n6–25\n21–38\n24–37\n23–37\n11–22\n23–29\n\nDirect\n\n Trials with method articles in guideline\n7 (12)\n0\n7 (6)\n2 (1)\n0\n1 (< 1)\n10 (1)\n\n\n Trials with result articles in guideline\n19 (32)\n4 (7)\n23 (19)\n36 (18)\n27 (16)\n18 (9)\n104 (15)\n\n\n Trials with register ID in guidelines\n3 (5)\n0\n3 (3)\n2 (1)\n2 (1)\n0\n7 (1)\n\n\n Trials with any direct citation\n25 (42)\n4 (7)\n29 (24)\n38 (19)\n29 (17)\n18 (9)\n114 (16)\n\nIndirect\n\n Trials in guidelines via review\n16 (27)\n8 (13)\n24 (20)\n43 (22)\n35 (20)\n20 (10)\n122 (18)\n\nDirect AND indirect\n\n Trials in guidelines via review AND result article\n12 (20)\n8 (13)\n20 (17)\n42 (21)\n35 (20)\n20 (10)\n117 (17)\n\n\n\nOpen in a new tab\nDirect: guidelines cite the original published article(s); Indirect: guidelines cite systematic review(s) that include the original published article(s)Sub-cohorts\nIn Fig. 7 / Table 5 it is shown that for the sub-cohorts the inclusion of trials in guidelines ranged between 17 and 31%.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Larger trials are about twice as often included in guidelines than smaller trials (Additional file 10).Overall impact\nLifecycle of trials\nFigure 8 shows the fate of the trials included in our cohort from registration to publication and to their impact on clinical practice.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Nevertheless, in our cohort, a relevant percentage did not find an inclusion in clinical practice: only 309 (45%) of the trials were included in systematic reviews and 178 (26%) in guidelines.Cohort\nOf all trials, 274 (40%) generated no impact: 115 (17%) of the trials were not published and of the published trials, 160 (23%) were not cited by either a systematic review or a guideline (Fig. 9).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "The distribution of the three “impact-proportions” concerning inclusion in reviews and/or guidelines showed only minor differences between the sub-cohorts (Fig. 10).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "The high proportion of guidelines in psychiatry and psychotherapy, cardiovascular disease and neurology is related to a high proportion of publications and systematic reviews for these fields (Fig. 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Our results, however, indicate that this only concerns a few trials because since 1) compared to literature, the publication rate of our cohort was relatively high, and 2) the stacked probability plot (Fig. 3) also indicates that only few first publications are to be expected.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Proportion of published trials\nFor our whole cohort, 576 (83%) of the 691 trials included were published as a method article or a result article in a medical journal and/or the trial results were made available in study registries; results were available for 555 (80%) of the trials (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For example, only 8% of the trials generated 29% of the publications, resulting in an average publication frequency of 7.0 (median 6) publications per trial.Sub-cohorts\nFor the sub-cohorts, the proportion of trials published varied between 77 and 87% (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "This was visualized as Aalen-Johansen estimators in a stacked probability plot (Fig. 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCumulative incidence functions (Aalen-Johansen estimates)Compared to Public Germany trials, results were published earlier for trials of the other sub-cohorts (Table 3, Fig. 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Frequently stated reasons for the exclusion of publications were that cohorts failed to meet the eligibility criteria and did not report the data of interest.Sub-cohorts\nFor the public sub-cohorts and for Commercial Germany, citation by systematic reviews ranged between 52 and 63% and was higher than in Commercial International with 38% (Fig. 5 and Table 4).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "This difference might be explained by the lower proportion of trials published as journal articles in ISTs (compare Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Both, the type of intervention and the number of primary outcomes are not associated with the inclusion probability, whereas larger trials are significantly more often included in reviews than smaller trials (Additional file 9).Trials included in clinical guidelines\nCohort\nWe found 574 citations of 178 trials (26%) in guidelines (Fig. 6).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Proportion of trials (n = 691) cited by clinical guidelines per sub-cohort and type of publication\n\n\nTrials cited by guideline\nIITPublic Germany govNo. of trials (%)\nIITPublic GermanyotherNo. of trials (%)\nIITPublic Germany(total)No. of trials (%)\nIITPublic InternationalNo. of trials (%)\nISTCommercial GermanyNo. of trials (%)\nISTCommercial InternationalNo. of trials (%)\nTotalNo. of trials(%)\n\n\n\nTotal trials\n60\n60\n120 (100)\n200 (100)\n171 (100)\n200 (100)\n691 (100)\n\n\nTrials in guidelines\n27 (45)\n8 (13)\n35 (29)\n61 (31)\n50 (29)\n32 (16)\n178 (26)\n\n\n95% CI\n32–58\n6–25\n21–38\n24–37\n23–37\n11–22\n23–29\n\nDirect\n\n Trials with method articles in guideline\n7 (12)\n0\n7 (6)\n2 (1)\n0\n1 (< 1)\n10 (1)\n\n\n Trials with result articles in guideline\n19 (32)\n4 (7)\n23 (19)\n36 (18)\n27 (16)\n18 (9)\n104 (15)\n\n\n Trials with register ID in guidelines\n3 (5)\n0\n3 (3)\n2 (1)\n2 (1)\n0\n7 (1)\n\n\n Trials with any direct citation\n25 (42)\n4 (7)\n29 (24)\n38 (19)\n29 (17)\n18 (9)\n114 (16)\n\nIndirect\n\n Trials in guidelines via review\n16 (27)\n8 (13)\n24 (20)\n43 (22)\n35 (20)\n20 (10)\n122 (18)\n\nDirect AND indirect\n\n Trials in guidelines via review AND result article\n12 (20)\n8 (13)\n20 (17)\n42 (21)\n35 (20)\n20 (10)\n117 (17)\n\n\n\nOpen in a new tab\nDirect: guidelines cite the original published article(s); Indirect: guidelines cite systematic review(s) that include the original published article(s)Sub-cohorts\nIn Fig. 7 / Table 5 it is shown that for the sub-cohorts the inclusion of trials in guidelines ranged between 17 and 31%.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Larger trials are about twice as often included in guidelines than smaller trials (Additional file 10).Overall impact\nLifecycle of trials\nFigure 8 shows the fate of the trials included in our cohort from registration to publication and to their impact on clinical practice.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Nevertheless, in our cohort, a relevant percentage did not find an inclusion in clinical practice: only 309 (45%) of the trials were included in systematic reviews and 178 (26%) in guidelines.Cohort\nOf all trials, 274 (40%) generated no impact: 115 (17%) of the trials were not published and of the published trials, 160 (23%) were not cited by either a systematic review or a guideline (Fig. 9).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "The distribution of the three “impact-proportions” concerning inclusion in reviews and/or guidelines showed only minor differences between the sub-cohorts (Fig. 10).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "The high proportion of guidelines in psychiatry and psychotherapy, cardiovascular disease and neurology is related to a high proportion of publications and systematic reviews for these fields (Fig. 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Our results, however, indicate that this only concerns a few trials because since 1) compared to literature, the publication rate of our cohort was relatively high, and 2) the stacked probability plot (Fig. 3) also indicates that only few first publications are to be expected.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Proportion of published trials\nFor our whole cohort, 576 (83%) of the 691 trials included were published as a method article or a result article in a medical journal and/or the trial results were made available in study registries; results were available for 555 (80%) of the trials (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For example, only 8% of the trials generated 29% of the publications, resulting in an average publication frequency of 7.0 (median 6) publications per trial.Sub-cohorts\nFor the sub-cohorts, the proportion of trials published varied between 77 and 87% (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "This was visualized as Aalen-Johansen estimators in a stacked probability plot (Fig. 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCumulative incidence functions (Aalen-Johansen estimates)Compared to Public Germany trials, results were published earlier for trials of the other sub-cohorts (Table 3, Fig. 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Frequently stated reasons for the exclusion of publications were that cohorts failed to meet the eligibility criteria and did not report the data of interest.Sub-cohorts\nFor the public sub-cohorts and for Commercial Germany, citation by systematic reviews ranged between 52 and 63% and was higher than in Commercial International with 38% (Fig. 5 and Table 4).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "This difference might be explained by the lower proportion of trials published as journal articles in ISTs (compare Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Both, the type of intervention and the number of primary outcomes are not associated with the inclusion probability, whereas larger trials are significantly more often included in reviews than smaller trials (Additional file 9).Trials included in clinical guidelines\nCohort\nWe found 574 citations of 178 trials (26%) in guidelines (Fig. 6).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Proportion of trials (n = 691) cited by clinical guidelines per sub-cohort and type of publication\n\n\nTrials cited by guideline\nIITPublic Germany govNo. of trials (%)\nIITPublic GermanyotherNo. of trials (%)\nIITPublic Germany(total)No. of trials (%)\nIITPublic InternationalNo. of trials (%)\nISTCommercial GermanyNo. of trials (%)\nISTCommercial InternationalNo. of trials (%)\nTotalNo. of trials(%)\n\n\n\nTotal trials\n60\n60\n120 (100)\n200 (100)\n171 (100)\n200 (100)\n691 (100)\n\n\nTrials in guidelines\n27 (45)\n8 (13)\n35 (29)\n61 (31)\n50 (29)\n32 (16)\n178 (26)\n\n\n95% CI\n32–58\n6–25\n21–38\n24–37\n23–37\n11–22\n23–29\n\nDirect\n\n Trials with method articles in guideline\n7 (12)\n0\n7 (6)\n2 (1)\n0\n1 (< 1)\n10 (1)\n\n\n Trials with result articles in guideline\n19 (32)\n4 (7)\n23 (19)\n36 (18)\n27 (16)\n18 (9)\n104 (15)\n\n\n Trials with register ID in guidelines\n3 (5)\n0\n3 (3)\n2 (1)\n2 (1)\n0\n7 (1)\n\n\n Trials with any direct citation\n25 (42)\n4 (7)\n29 (24)\n38 (19)\n29 (17)\n18 (9)\n114 (16)\n\nIndirect\n\n Trials in guidelines via review\n16 (27)\n8 (13)\n24 (20)\n43 (22)\n35 (20)\n20 (10)\n122 (18)\n\nDirect AND indirect\n\n Trials in guidelines via review AND result article\n12 (20)\n8 (13)\n20 (17)\n42 (21)\n35 (20)\n20 (10)\n117 (17)\n\n\n\nOpen in a new tab\nDirect: guidelines cite the original published article(s); Indirect: guidelines cite systematic review(s) that include the original published article(s)Sub-cohorts\nIn Fig. 7 / Table 5 it is shown that for the sub-cohorts the inclusion of trials in guidelines ranged between 17 and 31%.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Larger trials are about twice as often included in guidelines than smaller trials (Additional file 10).Overall impact\nLifecycle of trials\nFigure 8 shows the fate of the trials included in our cohort from registration to publication and to their impact on clinical practice.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Nevertheless, in our cohort, a relevant percentage did not find an inclusion in clinical practice: only 309 (45%) of the trials were included in systematic reviews and 178 (26%) in guidelines.Cohort\nOf all trials, 274 (40%) generated no impact: 115 (17%) of the trials were not published and of the published trials, 160 (23%) were not cited by either a systematic review or a guideline (Fig. 9).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "The distribution of the three “impact-proportions” concerning inclusion in reviews and/or guidelines showed only minor differences between the sub-cohorts (Fig. 10).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "The high proportion of guidelines in psychiatry and psychotherapy, cardiovascular disease and neurology is related to a high proportion of publications and systematic reviews for these fields (Fig. 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Our results, however, indicate that this only concerns a few trials because since 1) compared to literature, the publication rate of our cohort was relatively high, and 2) the stacked probability plot (Fig. 3) also indicates that only few first publications are to be expected.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Proportion of published trials\nFor our whole cohort, 576 (83%) of the 691 trials included were published as a method article or a result article in a medical journal and/or the trial results were made available in study registries; results were available for 555 (80%) of the trials (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For example, only 8% of the trials generated 29% of the publications, resulting in an average publication frequency of 7.0 (median 6) publications per trial.Sub-cohorts\nFor the sub-cohorts, the proportion of trials published varied between 77 and 87% (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "This was visualized as Aalen-Johansen estimators in a stacked probability plot (Fig. 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCumulative incidence functions (Aalen-Johansen estimates)Compared to Public Germany trials, results were published earlier for trials of the other sub-cohorts (Table 3, Fig. 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Frequently stated reasons for the exclusion of publications were that cohorts failed to meet the eligibility criteria and did not report the data of interest.Sub-cohorts\nFor the public sub-cohorts and for Commercial Germany, citation by systematic reviews ranged between 52 and 63% and was higher than in Commercial International with 38% (Fig. 5 and Table 4).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "This difference might be explained by the lower proportion of trials published as journal articles in ISTs (compare Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Both, the type of intervention and the number of primary outcomes are not associated with the inclusion probability, whereas larger trials are significantly more often included in reviews than smaller trials (Additional file 9).Trials included in clinical guidelines\nCohort\nWe found 574 citations of 178 trials (26%) in guidelines (Fig. 6).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Proportion of trials (n = 691) cited by clinical guidelines per sub-cohort and type of publication\n\n\nTrials cited by guideline\nIITPublic Germany govNo. of trials (%)\nIITPublic GermanyotherNo. of trials (%)\nIITPublic Germany(total)No. of trials (%)\nIITPublic InternationalNo. of trials (%)\nISTCommercial GermanyNo. of trials (%)\nISTCommercial InternationalNo. of trials (%)\nTotalNo. of trials(%)\n\n\n\nTotal trials\n60\n60\n120 (100)\n200 (100)\n171 (100)\n200 (100)\n691 (100)\n\n\nTrials in guidelines\n27 (45)\n8 (13)\n35 (29)\n61 (31)\n50 (29)\n32 (16)\n178 (26)\n\n\n95% CI\n32–58\n6–25\n21–38\n24–37\n23–37\n11–22\n23–29\n\nDirect\n\n Trials with method articles in guideline\n7 (12)\n0\n7 (6)\n2 (1)\n0\n1 (< 1)\n10 (1)\n\n\n Trials with result articles in guideline\n19 (32)\n4 (7)\n23 (19)\n36 (18)\n27 (16)\n18 (9)\n104 (15)\n\n\n Trials with register ID in guidelines\n3 (5)\n0\n3 (3)\n2 (1)\n2 (1)\n0\n7 (1)\n\n\n Trials with any direct citation\n25 (42)\n4 (7)\n29 (24)\n38 (19)\n29 (17)\n18 (9)\n114 (16)\n\nIndirect\n\n Trials in guidelines via review\n16 (27)\n8 (13)\n24 (20)\n43 (22)\n35 (20)\n20 (10)\n122 (18)\n\nDirect AND indirect\n\n Trials in guidelines via review AND result article\n12 (20)\n8 (13)\n20 (17)\n42 (21)\n35 (20)\n20 (10)\n117 (17)\n\n\n\nOpen in a new tab\nDirect: guidelines cite the original published article(s); Indirect: guidelines cite systematic review(s) that include the original published article(s)Sub-cohorts\nIn Fig. 7 / Table 5 it is shown that for the sub-cohorts the inclusion of trials in guidelines ranged between 17 and 31%.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Larger trials are about twice as often included in guidelines than smaller trials (Additional file 10).Overall impact\nLifecycle of trials\nFigure 8 shows the fate of the trials included in our cohort from registration to publication and to their impact on clinical practice.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Nevertheless, in our cohort, a relevant percentage did not find an inclusion in clinical practice: only 309 (45%) of the trials were included in systematic reviews and 178 (26%) in guidelines.Cohort\nOf all trials, 274 (40%) generated no impact: 115 (17%) of the trials were not published and of the published trials, 160 (23%) were not cited by either a systematic review or a guideline (Fig. 9).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "The distribution of the three “impact-proportions” concerning inclusion in reviews and/or guidelines showed only minor differences between the sub-cohorts (Fig. 10).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "The high proportion of guidelines in psychiatry and psychotherapy, cardiovascular disease and neurology is related to a high proportion of publications and systematic reviews for these fields (Fig. 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Our results, however, indicate that this only concerns a few trials because since 1) compared to literature, the publication rate of our cohort was relatively high, and 2) the stacked probability plot (Fig. 3) also indicates that only few first publications are to be expected.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Proportion of published trials\nFor our whole cohort, 576 (83%) of the 691 trials included were published as a method article or a result article in a medical journal and/or the trial results were made available in study registries; results were available for 555 (80%) of the trials (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For example, only 8% of the trials generated 29% of the publications, resulting in an average publication frequency of 7.0 (median 6) publications per trial.Sub-cohorts\nFor the sub-cohorts, the proportion of trials published varied between 77 and 87% (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "This was visualized as Aalen-Johansen estimators in a stacked probability plot (Fig. 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCumulative incidence functions (Aalen-Johansen estimates)Compared to Public Germany trials, results were published earlier for trials of the other sub-cohorts (Table 3, Fig. 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Frequently stated reasons for the exclusion of publications were that cohorts failed to meet the eligibility criteria and did not report the data of interest.Sub-cohorts\nFor the public sub-cohorts and for Commercial Germany, citation by systematic reviews ranged between 52 and 63% and was higher than in Commercial International with 38% (Fig. 5 and Table 4).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "This difference might be explained by the lower proportion of trials published as journal articles in ISTs (compare Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Both, the type of intervention and the number of primary outcomes are not associated with the inclusion probability, whereas larger trials are significantly more often included in reviews than smaller trials (Additional file 9).Trials included in clinical guidelines\nCohort\nWe found 574 citations of 178 trials (26%) in guidelines (Fig. 6).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Proportion of trials (n = 691) cited by clinical guidelines per sub-cohort and type of publication\n\n\nTrials cited by guideline\nIITPublic Germany govNo. of trials (%)\nIITPublic GermanyotherNo. of trials (%)\nIITPublic Germany(total)No. of trials (%)\nIITPublic InternationalNo. of trials (%)\nISTCommercial GermanyNo. of trials (%)\nISTCommercial InternationalNo. of trials (%)\nTotalNo. of trials(%)\n\n\n\nTotal trials\n60\n60\n120 (100)\n200 (100)\n171 (100)\n200 (100)\n691 (100)\n\n\nTrials in guidelines\n27 (45)\n8 (13)\n35 (29)\n61 (31)\n50 (29)\n32 (16)\n178 (26)\n\n\n95% CI\n32–58\n6–25\n21–38\n24–37\n23–37\n11–22\n23–29\n\nDirect\n\n Trials with method articles in guideline\n7 (12)\n0\n7 (6)\n2 (1)\n0\n1 (< 1)\n10 (1)\n\n\n Trials with result articles in guideline\n19 (32)\n4 (7)\n23 (19)\n36 (18)\n27 (16)\n18 (9)\n104 (15)\n\n\n Trials with register ID in guidelines\n3 (5)\n0\n3 (3)\n2 (1)\n2 (1)\n0\n7 (1)\n\n\n Trials with any direct citation\n25 (42)\n4 (7)\n29 (24)\n38 (19)\n29 (17)\n18 (9)\n114 (16)\n\nIndirect\n\n Trials in guidelines via review\n16 (27)\n8 (13)\n24 (20)\n43 (22)\n35 (20)\n20 (10)\n122 (18)\n\nDirect AND indirect\n\n Trials in guidelines via review AND result article\n12 (20)\n8 (13)\n20 (17)\n42 (21)\n35 (20)\n20 (10)\n117 (17)\n\n\n\nOpen in a new tab\nDirect: guidelines cite the original published article(s); Indirect: guidelines cite systematic review(s) that include the original published article(s)Sub-cohorts\nIn Fig. 7 / Table 5 it is shown that for the sub-cohorts the inclusion of trials in guidelines ranged between 17 and 31%.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Larger trials are about twice as often included in guidelines than smaller trials (Additional file 10).Overall impact\nLifecycle of trials\nFigure 8 shows the fate of the trials included in our cohort from registration to publication and to their impact on clinical practice.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Nevertheless, in our cohort, a relevant percentage did not find an inclusion in clinical practice: only 309 (45%) of the trials were included in systematic reviews and 178 (26%) in guidelines.Cohort\nOf all trials, 274 (40%) generated no impact: 115 (17%) of the trials were not published and of the published trials, 160 (23%) were not cited by either a systematic review or a guideline (Fig. 9).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "The distribution of the three “impact-proportions” concerning inclusion in reviews and/or guidelines showed only minor differences between the sub-cohorts (Fig. 10).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "The high proportion of guidelines in psychiatry and psychotherapy, cardiovascular disease and neurology is related to a high proportion of publications and systematic reviews for these fields (Fig. 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Our results, however, indicate that this only concerns a few trials because since 1) compared to literature, the publication rate of our cohort was relatively high, and 2) the stacked probability plot (Fig. 3) also indicates that only few first publications are to be expected.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Proportion of published trials\nFor our whole cohort, 576 (83%) of the 691 trials included were published as a method article or a result article in a medical journal and/or the trial results were made available in study registries; results were available for 555 (80%) of the trials (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For example, only 8% of the trials generated 29% of the publications, resulting in an average publication frequency of 7.0 (median 6) publications per trial.Sub-cohorts\nFor the sub-cohorts, the proportion of trials published varied between 77 and 87% (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "This was visualized as Aalen-Johansen estimators in a stacked probability plot (Fig. 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCumulative incidence functions (Aalen-Johansen estimates)Compared to Public Germany trials, results were published earlier for trials of the other sub-cohorts (Table 3, Fig. 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Frequently stated reasons for the exclusion of publications were that cohorts failed to meet the eligibility criteria and did not report the data of interest.Sub-cohorts\nFor the public sub-cohorts and for Commercial Germany, citation by systematic reviews ranged between 52 and 63% and was higher than in Commercial International with 38% (Fig. 5 and Table 4).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "This difference might be explained by the lower proportion of trials published as journal articles in ISTs (compare Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Both, the type of intervention and the number of primary outcomes are not associated with the inclusion probability, whereas larger trials are significantly more often included in reviews than smaller trials (Additional file 9).Trials included in clinical guidelines\nCohort\nWe found 574 citations of 178 trials (26%) in guidelines (Fig. 6).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Proportion of trials (n = 691) cited by clinical guidelines per sub-cohort and type of publication\n\n\nTrials cited by guideline\nIITPublic Germany govNo. of trials (%)\nIITPublic GermanyotherNo. of trials (%)\nIITPublic Germany(total)No. of trials (%)\nIITPublic InternationalNo. of trials (%)\nISTCommercial GermanyNo. of trials (%)\nISTCommercial InternationalNo. of trials (%)\nTotalNo. of trials(%)\n\n\n\nTotal trials\n60\n60\n120 (100)\n200 (100)\n171 (100)\n200 (100)\n691 (100)\n\n\nTrials in guidelines\n27 (45)\n8 (13)\n35 (29)\n61 (31)\n50 (29)\n32 (16)\n178 (26)\n\n\n95% CI\n32–58\n6–25\n21–38\n24–37\n23–37\n11–22\n23–29\n\nDirect\n\n Trials with method articles in guideline\n7 (12)\n0\n7 (6)\n2 (1)\n0\n1 (< 1)\n10 (1)\n\n\n Trials with result articles in guideline\n19 (32)\n4 (7)\n23 (19)\n36 (18)\n27 (16)\n18 (9)\n104 (15)\n\n\n Trials with register ID in guidelines\n3 (5)\n0\n3 (3)\n2 (1)\n2 (1)\n0\n7 (1)\n\n\n Trials with any direct citation\n25 (42)\n4 (7)\n29 (24)\n38 (19)\n29 (17)\n18 (9)\n114 (16)\n\nIndirect\n\n Trials in guidelines via review\n16 (27)\n8 (13)\n24 (20)\n43 (22)\n35 (20)\n20 (10)\n122 (18)\n\nDirect AND indirect\n\n Trials in guidelines via review AND result article\n12 (20)\n8 (13)\n20 (17)\n42 (21)\n35 (20)\n20 (10)\n117 (17)\n\n\n\nOpen in a new tab\nDirect: guidelines cite the original published article(s); Indirect: guidelines cite systematic review(s) that include the original published article(s)Sub-cohorts\nIn Fig. 7 / Table 5 it is shown that for the sub-cohorts the inclusion of trials in guidelines ranged between 17 and 31%.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Larger trials are about twice as often included in guidelines than smaller trials (Additional file 10).Overall impact\nLifecycle of trials\nFigure 8 shows the fate of the trials included in our cohort from registration to publication and to their impact on clinical practice.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Nevertheless, in our cohort, a relevant percentage did not find an inclusion in clinical practice: only 309 (45%) of the trials were included in systematic reviews and 178 (26%) in guidelines.Cohort\nOf all trials, 274 (40%) generated no impact: 115 (17%) of the trials were not published and of the published trials, 160 (23%) were not cited by either a systematic review or a guideline (Fig. 9).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "The distribution of the three “impact-proportions” concerning inclusion in reviews and/or guidelines showed only minor differences between the sub-cohorts (Fig. 10).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "The high proportion of guidelines in psychiatry and psychotherapy, cardiovascular disease and neurology is related to a high proportion of publications and systematic reviews for these fields (Fig. 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Our results, however, indicate that this only concerns a few trials because since 1) compared to literature, the publication rate of our cohort was relatively high, and 2) the stacked probability plot (Fig. 3) also indicates that only few first publications are to be expected.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Proportion of published trials\nFor our whole cohort, 576 (83%) of the 691 trials included were published as a method article or a result article in a medical journal and/or the trial results were made available in study registries; results were available for 555 (80%) of the trials (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For example, only 8% of the trials generated 29% of the publications, resulting in an average publication frequency of 7.0 (median 6) publications per trial.Sub-cohorts\nFor the sub-cohorts, the proportion of trials published varied between 77 and 87% (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "This was visualized as Aalen-Johansen estimators in a stacked probability plot (Fig. 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCumulative incidence functions (Aalen-Johansen estimates)Compared to Public Germany trials, results were published earlier for trials of the other sub-cohorts (Table 3, Fig. 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Frequently stated reasons for the exclusion of publications were that cohorts failed to meet the eligibility criteria and did not report the data of interest.Sub-cohorts\nFor the public sub-cohorts and for Commercial Germany, citation by systematic reviews ranged between 52 and 63% and was higher than in Commercial International with 38% (Fig. 5 and Table 4).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "This difference might be explained by the lower proportion of trials published as journal articles in ISTs (compare Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Both, the type of intervention and the number of primary outcomes are not associated with the inclusion probability, whereas larger trials are significantly more often included in reviews than smaller trials (Additional file 9).Trials included in clinical guidelines\nCohort\nWe found 574 citations of 178 trials (26%) in guidelines (Fig. 6).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Proportion of trials (n = 691) cited by clinical guidelines per sub-cohort and type of publication\n\n\nTrials cited by guideline\nIITPublic Germany govNo. of trials (%)\nIITPublic GermanyotherNo. of trials (%)\nIITPublic Germany(total)No. of trials (%)\nIITPublic InternationalNo. of trials (%)\nISTCommercial GermanyNo. of trials (%)\nISTCommercial InternationalNo. of trials (%)\nTotalNo. of trials(%)\n\n\n\nTotal trials\n60\n60\n120 (100)\n200 (100)\n171 (100)\n200 (100)\n691 (100)\n\n\nTrials in guidelines\n27 (45)\n8 (13)\n35 (29)\n61 (31)\n50 (29)\n32 (16)\n178 (26)\n\n\n95% CI\n32–58\n6–25\n21–38\n24–37\n23–37\n11–22\n23–29\n\nDirect\n\n Trials with method articles in guideline\n7 (12)\n0\n7 (6)\n2 (1)\n0\n1 (< 1)\n10 (1)\n\n\n Trials with result articles in guideline\n19 (32)\n4 (7)\n23 (19)\n36 (18)\n27 (16)\n18 (9)\n104 (15)\n\n\n Trials with register ID in guidelines\n3 (5)\n0\n3 (3)\n2 (1)\n2 (1)\n0\n7 (1)\n\n\n Trials with any direct citation\n25 (42)\n4 (7)\n29 (24)\n38 (19)\n29 (17)\n18 (9)\n114 (16)\n\nIndirect\n\n Trials in guidelines via review\n16 (27)\n8 (13)\n24 (20)\n43 (22)\n35 (20)\n20 (10)\n122 (18)\n\nDirect AND indirect\n\n Trials in guidelines via review AND result article\n12 (20)\n8 (13)\n20 (17)\n42 (21)\n35 (20)\n20 (10)\n117 (17)\n\n\n\nOpen in a new tab\nDirect: guidelines cite the original published article(s); Indirect: guidelines cite systematic review(s) that include the original published article(s)Sub-cohorts\nIn Fig. 7 / Table 5 it is shown that for the sub-cohorts the inclusion of trials in guidelines ranged between 17 and 31%.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Larger trials are about twice as often included in guidelines than smaller trials (Additional file 10).Overall impact\nLifecycle of trials\nFigure 8 shows the fate of the trials included in our cohort from registration to publication and to their impact on clinical practice.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Nevertheless, in our cohort, a relevant percentage did not find an inclusion in clinical practice: only 309 (45%) of the trials were included in systematic reviews and 178 (26%) in guidelines.Cohort\nOf all trials, 274 (40%) generated no impact: 115 (17%) of the trials were not published and of the published trials, 160 (23%) were not cited by either a systematic review or a guideline (Fig. 9).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "The distribution of the three “impact-proportions” concerning inclusion in reviews and/or guidelines showed only minor differences between the sub-cohorts (Fig. 10).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "The high proportion of guidelines in psychiatry and psychotherapy, cardiovascular disease and neurology is related to a high proportion of publications and systematic reviews for these fields (Fig. 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Our results, however, indicate that this only concerns a few trials because since 1) compared to literature, the publication rate of our cohort was relatively high, and 2) the stacked probability plot (Fig. 3) also indicates that only few first publications are to be expected.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Proportion of published trials\nFor our whole cohort, 576 (83%) of the 691 trials included were published as a method article or a result article in a medical journal and/or the trial results were made available in study registries; results were available for 555 (80%) of the trials (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For example, only 8% of the trials generated 29% of the publications, resulting in an average publication frequency of 7.0 (median 6) publications per trial.Sub-cohorts\nFor the sub-cohorts, the proportion of trials published varied between 77 and 87% (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "This was visualized as Aalen-Johansen estimators in a stacked probability plot (Fig. 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCumulative incidence functions (Aalen-Johansen estimates)Compared to Public Germany trials, results were published earlier for trials of the other sub-cohorts (Table 3, Fig. 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Frequently stated reasons for the exclusion of publications were that cohorts failed to meet the eligibility criteria and did not report the data of interest.Sub-cohorts\nFor the public sub-cohorts and for Commercial Germany, citation by systematic reviews ranged between 52 and 63% and was higher than in Commercial International with 38% (Fig. 5 and Table 4).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "This difference might be explained by the lower proportion of trials published as journal articles in ISTs (compare Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Both, the type of intervention and the number of primary outcomes are not associated with the inclusion probability, whereas larger trials are significantly more often included in reviews than smaller trials (Additional file 9).Trials included in clinical guidelines\nCohort\nWe found 574 citations of 178 trials (26%) in guidelines (Fig. 6).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Proportion of trials (n = 691) cited by clinical guidelines per sub-cohort and type of publication\n\n\nTrials cited by guideline\nIITPublic Germany govNo. of trials (%)\nIITPublic GermanyotherNo. of trials (%)\nIITPublic Germany(total)No. of trials (%)\nIITPublic InternationalNo. of trials (%)\nISTCommercial GermanyNo. of trials (%)\nISTCommercial InternationalNo. of trials (%)\nTotalNo. of trials(%)\n\n\n\nTotal trials\n60\n60\n120 (100)\n200 (100)\n171 (100)\n200 (100)\n691 (100)\n\n\nTrials in guidelines\n27 (45)\n8 (13)\n35 (29)\n61 (31)\n50 (29)\n32 (16)\n178 (26)\n\n\n95% CI\n32–58\n6–25\n21–38\n24–37\n23–37\n11–22\n23–29\n\nDirect\n\n Trials with method articles in guideline\n7 (12)\n0\n7 (6)\n2 (1)\n0\n1 (< 1)\n10 (1)\n\n\n Trials with result articles in guideline\n19 (32)\n4 (7)\n23 (19)\n36 (18)\n27 (16)\n18 (9)\n104 (15)\n\n\n Trials with register ID in guidelines\n3 (5)\n0\n3 (3)\n2 (1)\n2 (1)\n0\n7 (1)\n\n\n Trials with any direct citation\n25 (42)\n4 (7)\n29 (24)\n38 (19)\n29 (17)\n18 (9)\n114 (16)\n\nIndirect\n\n Trials in guidelines via review\n16 (27)\n8 (13)\n24 (20)\n43 (22)\n35 (20)\n20 (10)\n122 (18)\n\nDirect AND indirect\n\n Trials in guidelines via review AND result article\n12 (20)\n8 (13)\n20 (17)\n42 (21)\n35 (20)\n20 (10)\n117 (17)\n\n\n\nOpen in a new tab\nDirect: guidelines cite the original published article(s); Indirect: guidelines cite systematic review(s) that include the original published article(s)Sub-cohorts\nIn Fig. 7 / Table 5 it is shown that for the sub-cohorts the inclusion of trials in guidelines ranged between 17 and 31%.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Larger trials are about twice as often included in guidelines than smaller trials (Additional file 10).Overall impact\nLifecycle of trials\nFigure 8 shows the fate of the trials included in our cohort from registration to publication and to their impact on clinical practice.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Nevertheless, in our cohort, a relevant percentage did not find an inclusion in clinical practice: only 309 (45%) of the trials were included in systematic reviews and 178 (26%) in guidelines.Cohort\nOf all trials, 274 (40%) generated no impact: 115 (17%) of the trials were not published and of the published trials, 160 (23%) were not cited by either a systematic review or a guideline (Fig. 9).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "The distribution of the three “impact-proportions” concerning inclusion in reviews and/or guidelines showed only minor differences between the sub-cohorts (Fig. 10).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "The high proportion of guidelines in psychiatry and psychotherapy, cardiovascular disease and neurology is related to a high proportion of publications and systematic reviews for these fields (Fig. 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Proportion of published trials\nFor our whole cohort, 576 (83%) of the 691 trials included were published as a method article or a result article in a medical journal and/or the trial results were made available in study registries; results were available for 555 (80%) of the trials (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For example, only 8% of the trials generated 29% of the publications, resulting in an average publication frequency of 7.0 (median 6) publications per trial.Sub-cohorts\nFor the sub-cohorts, the proportion of trials published varied between 77 and 87% (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Proportion of published trials\nFor our whole cohort, 576 (83%) of the 691 trials included were published as a method article or a result article in a medical journal and/or the trial results were made available in study registries; results were available for 555 (80%) of the trials (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For our whole cohort, 576 (83%) of the 691 trials included were published as a method article or a result article in a medical journal and/or the trial results were made available in study registries; results were available for 555 (80%) of the trials (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For example, only 8% of the trials generated 29% of the publications, resulting in an average publication frequency of 7.0 (median 6) publications per trial.Sub-cohorts\nFor the sub-cohorts, the proportion of trials published varied between 77 and 87% (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Sub-cohorts\nFor the sub-cohorts, the proportion of trials published varied between 77 and 87% (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "For the sub-cohorts, the proportion of trials published varied between 77 and 87% (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "This was visualized as Aalen-Johansen estimators in a stacked probability plot (Fig. 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCumulative incidence functions (Aalen-Johansen estimates)Compared to Public Germany trials, results were published earlier for trials of the other sub-cohorts (Table 3, Fig. 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "This was visualized as Aalen-Johansen estimators in a stacked probability plot (Fig. 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Compared to Public Germany trials, results were published earlier for trials of the other sub-cohorts (Table 3, Fig. 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Frequently stated reasons for the exclusion of publications were that cohorts failed to meet the eligibility criteria and did not report the data of interest.Sub-cohorts\nFor the public sub-cohorts and for Commercial Germany, citation by systematic reviews ranged between 52 and 63% and was higher than in Commercial International with 38% (Fig. 5 and Table 4).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "This difference might be explained by the lower proportion of trials published as journal articles in ISTs (compare Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Both, the type of intervention and the number of primary outcomes are not associated with the inclusion probability, whereas larger trials are significantly more often included in reviews than smaller trials (Additional file 9).Trials included in clinical guidelines\nCohort\nWe found 574 citations of 178 trials (26%) in guidelines (Fig. 6).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Proportion of trials (n = 691) cited by clinical guidelines per sub-cohort and type of publication\n\n\nTrials cited by guideline\nIITPublic Germany govNo. of trials (%)\nIITPublic GermanyotherNo. of trials (%)\nIITPublic Germany(total)No. of trials (%)\nIITPublic InternationalNo. of trials (%)\nISTCommercial GermanyNo. of trials (%)\nISTCommercial InternationalNo. of trials (%)\nTotalNo. of trials(%)\n\n\n\nTotal trials\n60\n60\n120 (100)\n200 (100)\n171 (100)\n200 (100)\n691 (100)\n\n\nTrials in guidelines\n27 (45)\n8 (13)\n35 (29)\n61 (31)\n50 (29)\n32 (16)\n178 (26)\n\n\n95% CI\n32–58\n6–25\n21–38\n24–37\n23–37\n11–22\n23–29\n\nDirect\n\n Trials with method articles in guideline\n7 (12)\n0\n7 (6)\n2 (1)\n0\n1 (< 1)\n10 (1)\n\n\n Trials with result articles in guideline\n19 (32)\n4 (7)\n23 (19)\n36 (18)\n27 (16)\n18 (9)\n104 (15)\n\n\n Trials with register ID in guidelines\n3 (5)\n0\n3 (3)\n2 (1)\n2 (1)\n0\n7 (1)\n\n\n Trials with any direct citation\n25 (42)\n4 (7)\n29 (24)\n38 (19)\n29 (17)\n18 (9)\n114 (16)\n\nIndirect\n\n Trials in guidelines via review\n16 (27)\n8 (13)\n24 (20)\n43 (22)\n35 (20)\n20 (10)\n122 (18)\n\nDirect AND indirect\n\n Trials in guidelines via review AND result article\n12 (20)\n8 (13)\n20 (17)\n42 (21)\n35 (20)\n20 (10)\n117 (17)\n\n\n\nOpen in a new tab\nDirect: guidelines cite the original published article(s); Indirect: guidelines cite systematic review(s) that include the original published article(s)Sub-cohorts\nIn Fig. 7 / Table 5 it is shown that for the sub-cohorts the inclusion of trials in guidelines ranged between 17 and 31%.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Larger trials are about twice as often included in guidelines than smaller trials (Additional file 10).Overall impact\nLifecycle of trials\nFigure 8 shows the fate of the trials included in our cohort from registration to publication and to their impact on clinical practice.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Nevertheless, in our cohort, a relevant percentage did not find an inclusion in clinical practice: only 309 (45%) of the trials were included in systematic reviews and 178 (26%) in guidelines.Cohort\nOf all trials, 274 (40%) generated no impact: 115 (17%) of the trials were not published and of the published trials, 160 (23%) were not cited by either a systematic review or a guideline (Fig. 9).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "The distribution of the three “impact-proportions” concerning inclusion in reviews and/or guidelines showed only minor differences between the sub-cohorts (Fig. 10).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "The high proportion of guidelines in psychiatry and psychotherapy, cardiovascular disease and neurology is related to a high proportion of publications and systematic reviews for these fields (Fig. 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Frequently stated reasons for the exclusion of publications were that cohorts failed to meet the eligibility criteria and did not report the data of interest.Sub-cohorts\nFor the public sub-cohorts and for Commercial Germany, citation by systematic reviews ranged between 52 and 63% and was higher than in Commercial International with 38% (Fig. 5 and Table 4).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "This difference might be explained by the lower proportion of trials published as journal articles in ISTs (compare Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Sub-cohorts\nFor the public sub-cohorts and for Commercial Germany, citation by systematic reviews ranged between 52 and 63% and was higher than in Commercial International with 38% (Fig. 5 and Table 4).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "This difference might be explained by the lower proportion of trials published as journal articles in ISTs (compare Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "For the public sub-cohorts and for Commercial Germany, citation by systematic reviews ranged between 52 and 63% and was higher than in Commercial International with 38% (Fig. 5 and Table 4).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "This difference might be explained by the lower proportion of trials published as journal articles in ISTs (compare Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Trials included in clinical guidelines\nCohort\nWe found 574 citations of 178 trials (26%) in guidelines (Fig. 6).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Proportion of trials (n = 691) cited by clinical guidelines per sub-cohort and type of publication\n\n\nTrials cited by guideline\nIITPublic Germany govNo. of trials (%)\nIITPublic GermanyotherNo. of trials (%)\nIITPublic Germany(total)No. of trials (%)\nIITPublic InternationalNo. of trials (%)\nISTCommercial GermanyNo. of trials (%)\nISTCommercial InternationalNo. of trials (%)\nTotalNo. of trials(%)\n\n\n\nTotal trials\n60\n60\n120 (100)\n200 (100)\n171 (100)\n200 (100)\n691 (100)\n\n\nTrials in guidelines\n27 (45)\n8 (13)\n35 (29)\n61 (31)\n50 (29)\n32 (16)\n178 (26)\n\n\n95% CI\n32–58\n6–25\n21–38\n24–37\n23–37\n11–22\n23–29\n\nDirect\n\n Trials with method articles in guideline\n7 (12)\n0\n7 (6)\n2 (1)\n0\n1 (< 1)\n10 (1)\n\n\n Trials with result articles in guideline\n19 (32)\n4 (7)\n23 (19)\n36 (18)\n27 (16)\n18 (9)\n104 (15)\n\n\n Trials with register ID in guidelines\n3 (5)\n0\n3 (3)\n2 (1)\n2 (1)\n0\n7 (1)\n\n\n Trials with any direct citation\n25 (42)\n4 (7)\n29 (24)\n38 (19)\n29 (17)\n18 (9)\n114 (16)\n\nIndirect\n\n Trials in guidelines via review\n16 (27)\n8 (13)\n24 (20)\n43 (22)\n35 (20)\n20 (10)\n122 (18)\n\nDirect AND indirect\n\n Trials in guidelines via review AND result article\n12 (20)\n8 (13)\n20 (17)\n42 (21)\n35 (20)\n20 (10)\n117 (17)\n\n\n\nOpen in a new tab\nDirect: guidelines cite the original published article(s); Indirect: guidelines cite systematic review(s) that include the original published article(s)Sub-cohorts\nIn Fig. 7 / Table 5 it is shown that for the sub-cohorts the inclusion of trials in guidelines ranged between 17 and 31%.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Cohort\nWe found 574 citations of 178 trials (26%) in guidelines (Fig. 6).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "We found 574 citations of 178 trials (26%) in guidelines (Fig. 6).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Sub-cohorts\nIn Fig. 7 / Table 5 it is shown that for the sub-cohorts the inclusion of trials in guidelines ranged between 17 and 31%.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "In Fig. 7 / Table 5 it is shown that for the sub-cohorts the inclusion of trials in guidelines ranged between 17 and 31%.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Overall impact\nLifecycle of trials\nFigure 8 shows the fate of the trials included in our cohort from registration to publication and to their impact on clinical practice.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Nevertheless, in our cohort, a relevant percentage did not find an inclusion in clinical practice: only 309 (45%) of the trials were included in systematic reviews and 178 (26%) in guidelines.Cohort\nOf all trials, 274 (40%) generated no impact: 115 (17%) of the trials were not published and of the published trials, 160 (23%) were not cited by either a systematic review or a guideline (Fig. 9).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "The distribution of the three “impact-proportions” concerning inclusion in reviews and/or guidelines showed only minor differences between the sub-cohorts (Fig. 10).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Lifecycle of trials\nFigure 8 shows the fate of the trials included in our cohort from registration to publication and to their impact on clinical practice.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Figure 8 shows the fate of the trials included in our cohort from registration to publication and to their impact on clinical practice.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Cohort\nOf all trials, 274 (40%) generated no impact: 115 (17%) of the trials were not published and of the published trials, 160 (23%) were not cited by either a systematic review or a guideline (Fig. 9).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Of all trials, 274 (40%) generated no impact: 115 (17%) of the trials were not published and of the published trials, 160 (23%) were not cited by either a systematic review or a guideline (Fig. 9).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "The distribution of the three “impact-proportions” concerning inclusion in reviews and/or guidelines showed only minor differences between the sub-cohorts (Fig. 10).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "The distribution of the three “impact-proportions” concerning inclusion in reviews and/or guidelines showed only minor differences between the sub-cohorts (Fig. 10).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "The high proportion of guidelines in psychiatry and psychotherapy, cardiovascular disease and neurology is related to a high proportion of publications and systematic reviews for these fields (Fig. 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "The high proportion of guidelines in psychiatry and psychotherapy, cardiovascular disease and neurology is related to a high proportion of publications and systematic reviews for these fields (Fig. 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Our results, however, indicate that this only concerns a few trials because since 1) compared to literature, the publication rate of our cohort was relatively high, and 2) the stacked probability plot (Fig. 3) also indicates that only few first publications are to be expected.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Our results, however, indicate that this only concerns a few trials because since 1) compared to literature, the publication rate of our cohort was relatively high, and 2) the stacked probability plot (Fig. 3) also indicates that only few first publications are to be expected.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Our results, however, indicate that this only concerns a few trials because since 1) compared to literature, the publication rate of our cohort was relatively high, and 2) the stacked probability plot (Fig. 3) also indicates that only few first publications are to be expected.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  }
]